Skip to main content
Equibles
DGX logo

DGX · Quest Diagnostics Inc · Metrics

Track DGX — free

Use DGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$254.74 -0.94 (-0.37%) At close · Nov 5 Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$28.13B
Shares
110.02M
Volume · Nov 5 969.56K Avg daily vol (3M) 1M

DGX metrics

115 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$254.74
Market cap
$28.13B

Price action

20 metrics
Price change (1W)
+4.1%
Price change (30D)
+11.9%
Price change (3M)
+8.4%
Price change (6M)
+35.2%
Price change (YTD)
+47.3%
Price change (1Y)
+43.6%
Trailing year
Price change (5Y)
+77.8%
52-week high
$255.68
52-week low
$173.49
Change from 52-week high
+0.0%
Change from 52-week low
+47.4%
Annualized volatility
24.2%
Annualized volatility (3M)
21.7%
Beta
-0.1
RSI (14D)
67.7
Price vs SMA 50
+7.0%
Price vs SMA 200
+20.0%
Avg volume (3M)
996,515
Relative volume
0.9
Average dollar volume
$238.08M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
110.02M

Valuation

12 metrics
P / E (TTM)
25.5
Trailing earnings · reciprocal yield 3.9%
PEG ratio
0.9
EV / revenue
2.8×
reciprocal yield 36.0%
EV / EBITDA
14.2×
reciprocal yield 7.0%
EV / EBIT
19.1×
reciprocal yield 5.2%
P / sales
2.4×
reciprocal yield 42.1%
P / book
3.7
reciprocal yield 27.1%
FCF yield
4.9%
TTM · current market cap
Buyback yield
2.0%
P / FCF
20.5
reciprocal yield 4.9%
P / operating cash flow
14.4
reciprocal yield 6.9%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
21.2×
reciprocal yield 4.7%
P / E historical average (5Y)
18.8×
reciprocal yield 5.3%
EV / revenue historical average (3Y)
2.3×
reciprocal yield 42.6%
EV / revenue historical average (5Y)
2.2×
reciprocal yield 45.9%
EV / EBIT historical average (3Y)
17.1×
reciprocal yield 5.9%
EV / EBIT historical average (5Y)
15.2×
reciprocal yield 6.6%
EV / EBITDA historical average (3Y)
12.5×
reciprocal yield 8.0%
EV / EBITDA historical average (5Y)
11.3×
reciprocal yield 8.8%

Dividends & buybacks

7 metrics
Dividend yield
1.3%
Trailing 12 months
Payout ratio
32.7%
Shareholder yield
—
Dividend / share (TTM)
$3.38
Dividend growth YoY
+7.3%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-10-06

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-22

Profitability

9 metrics
Gross margin
33.1%
Operating margin
14.6%
Trailing 12 months
Net margin
9.5%
Gross profit (TTM)
$3.92B
Operating profit (TTM)
$1.72B
Net income (TTM)
$1.13B
Trailing 12 months
Diluted EPS (TTM)
$10.04
FCF margin
11.6%
Effective tax rate
22.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$105.50
Gross profit per diluted share (TTM)
$34.94
Operating profit per diluted share (TTM)
$15.35
EBITDA per diluted share (TTM)
$20.57
Net income per diluted share (TTM)
$10.06
Operating cash flow per diluted share (TTM)
$17.38
Free cash flow per diluted share (TTM)
$12.25
Capital expenditures per diluted share (TTM)
$5.13
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.78
Book value per share
$22.30

Growth

11 metrics
Revenue growth YoY
+10.0%
Year over year
Net income growth YoY
+27.3%
Revenue (TTM)
$11.84B
Trailing 12 months
EPS growth YoY
+28.7%
Shares change YoY
-0.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+3.7%
Revenue CAGR (5Y)
+3.2%
EPS CAGR (3Y)
+3.2%
EPS CAGR (5Y)
-3.5%
FCF CAGR (3Y)
+1.1%
FCF CAGR (5Y)
-3.1%

Quality

14 metrics
Return on equity
14.8%
Return on assets
6.6%
Debt / equity
0.7
Current ratio
1.7
EBITDA (TTM)
$2.31B
Free cash flow (TTM)
$1.38B
Quick ratio
1.6
Interest coverage
6.5
Net debt / EBITDA
2.1
Return on invested capital
10.7%
Trailing 12 months
Net cash
−$4.75B
Latest balance sheet
Cash & equivalents
$797.00M
Total assets
$17.22B
Total debt
$5.55B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.95B
Capital expenditures (TTM)
$576.00M
R&D (TTM)
—
SG&A (TTM)
$2.06B
Stock compensation (TTM)
$88.00M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

9 metrics
13F filers
1,119
13F filer change QoQ
+43
Institutional ownership
95.9%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
22.3%
Private-fund adviser ownership
22.0%
Active holders' share change QoQ
+0.7%
Holder tenure
17.1
Price vs estimated holder cost
+20.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.7%

Short interest

3 metrics
Short interest
3.2%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$13.72M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1022079 CUSIP 74834L100 13F (30d) 604 filings 555 filers Visit website Investor relations